Shop
Description
TRAJENTA TAB 5MG contains linagliptin as the active ingredient.
Primary Uses:
– Used to improve blood sugar control in adults with type 2 diabetes mellitus.
– Often prescribed as part of a treatment plan including diet and exercise.
Drug Class or Type:
– Dipeptidyl peptidase-4 (DPP-4) inhibitor, an oral antihyperglycemic agent.
General Mechanism of Action:
– Linagliptin works by inhibiting the DPP-4 enzyme, which increases the levels of incretin hormones in the body.
– These hormones help to regulate blood glucose by increasing insulin release and decreasing the amount of glucose produced by the liver.
Common Forms:
– Oral tablets, 5 mg strength.
Dosage Instructions:
– The usual dose is one 5 mg tablet taken once daily, with or without food.
– Dosage adjustments are generally not required for patients with renal impairment.
– It is important to follow the healthcare provider’s instructions regarding dosage and administration.
Side Effects, Contraindications, or Interactions:
– Common side effects may include nasopharyngitis, cough, and headache.
– Contraindicated in patients with known hypersensitivity to linagliptin.
– Use caution in patients with pancreatitis history or severe renal impairment.
– May interact with other diabetes medications; inform healthcare provider of all medications being taken.
Use under medical supervision as part of a comprehensive diabetes management plan.
Reviews
There are no reviews yet.